Developmental regulation of perlecan gene expression in aortic smooth muscle cells

Matrix Biology

Volumn 15, Issue 5, 1996, Pages 331-340

  Weiser, Mary C M ^a   Belknap, James K ^a   Grieshaber, Scott S ^a   Kinsella, Michael G ^b   Majack, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Development; Gene expression; Perlecan heparan sulfate; Smooth muscle cells

Indexed keywords

BROXURIDINE; MESSENGER RNA; PERLECAN; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; AORTA WALL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0030297696     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(96)90136-5     Document Type: Article

References (33)

1. Belknap J.K., Grieshaber N.A., Schwartz P.E., Orton E.C., Reidy M.A., Majack R.A. Tropoelastin gene expression in individual vascular smooth muscle cells: relationship to DNA synthesis during vascular development and after arterial injury. Circ. Res. 78:1996;388-394.
2. Benitz W.E., Kelley R.T., Anderson C.M., Lorant D.E., Bernfield M. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am. J. Resp. Cell Molec. Biol. 2:1990;13-24.
3. Campbell J.H., Bennick R.E., Kalevitch S., Campbell G.R. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp. Cell Res. 200:1992;156-167.
4. Castellot J.J., Addonzio M.L., Rosenberg R.D., Karnovsky M.J. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J. Cell Biol. 90:1981;372-379.
5. Chamley-Campbell J.H., Campbell G.R., Ross R. Phenotype-dependent response of cultured aortic smooth muscle cells to serum mitogens. J. Cell Biol. 89:1981;379-383.
6. Clowes A.W., Karnovsky M.J. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 265:1977;625-626.
7. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327-333.
8. Cohen I.R., Grassel S., Murdoch A.D., Iozzo R.V. Structural characterization of the complete human perlecan gene and its promoter. Proc. Natl. Acad. Sci. USA. 90:1993;10404-10408.
9. Cohen I.R., Murdoch A.D., Naso M.F., Marchetti D., Berd D., Iozzo R.V. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res. 54:1994;5771-5774.
10. Cook C.L., Weiser M.C.M., Schwartz P.E., Jones C.L., Majack R.A. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ. Res. 74:1994;189-196.
11. Fritze L.M., Reilly C.F., Rosenberg R.D. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J. Cell Biol. 100:1985;1041-1049.
12. Hassell J.R., Robey P.G., Barrach H.J., Wilczek J., Rennard S.I., Martin G.R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA. 77:1980;4494-4498.
13. Hayashi K., Madri J.A., Yurchenco P.D. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 2 integrins: an adhesion modulated by glycosaminoglycans. J. Cell Biol. 119:1992;945-959.
14. Hedin U., Bottger B.A., Forsberg E., Johansson S., Thyberg J. Diverse effects of fibronectin and laminin on phenotypic modulation of cultured arterial smooth muscle cells. J. Cell Biol. 107:1988;307-319.
15. Li X., Tsai P., Wieder E.D., Kribben A., Van Putten V., Schrier R.W., Nemenoff R.A.S. Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J. Biol. Chem. 265:1994;19653-19658.
16. Lindner V., Lappi D.A., Baird A., Majack R.A., Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68:1991;106-113.
17. Majack R.A., Clowes A.W. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell Physiol. 118:1984;253-256.
18. Majack R.A. Extinction of autonomous growth potential in embryonic: adult vascular smooth muscle cell heterokaryons. J. Clin. Invest. 95:1995;464-468.
19. McHugh K.M., Lessard J.L. The nucleotide sequence of a rat vascular smooth muscle α-actin cDNA. Nucleic Acids Res. 16:1988;4167.
20. Murdoch A.D., Dodge G.R., Cohen I., Tuzan R.S., Iozzo R.V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). J. Biol. Chem. 267:1992;8544-8557.
21. Murdoch A.D., Liu B., Schwarting R., Tuan R.S., Iozzo R.V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42:1994;239-249.
22. Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., Hassell J.R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266:1991;22939-22947.
23. Noonan D.M., Hassell J.R. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 43:1993;53-60.
24. Pauly R.R., Passaniti A., Crow M., Kinsella J.L., Papadopoulos N., Monticone R., Ladatta E.G., Martin G.R. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation. 86:(Suppl. III):1992;68-73.
25. Pukac L.A., Ottlinger M.E., Karnovsky M.J. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267:1992;3707-3711.
26. Sambrook J., Fritsch E.F., Maniatis R. Second Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
27. Schmidt A., Buddeeke E. Bovine arterial smooth muscle cells synthetize two functionally different proteoheparan sulfate species. Exp. Cells. Res. 189:1990;269-275.
28. Snow A.D., Bolender R.P., Wight T.N., Clowes A.W. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am. J. Pathol. 137:1990;313-330.
29. Thyberg J., Palmberg L., Nilsson J., Ksiazek T., Sjolund M. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation. 25:1983;156-167.
30. Thyberg J., Hedin U., Sjölund M., Palmberg L., Bottger B.A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:1990;966-990.
31. Weiser M.C.M., Majack R.A., Tucker A., Orton C. Static tension is associated with increased smooth muscle cell DNA synthesis in rat pulmonary arteries. Amer. J. Physiol. 268:1995;H1133-H1138.
32. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., DePaepe A., Tryggvason K., Reeders S.T. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science. 261:1993;1167-1169.
33. Dr. Mary C. M. Weiser, Department of Pediatrics, Campus Box B131, University of Colorado Health Sciences Center, Denver, CO 80262.